MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treat...
Leadership
Jorge Santos da Silva Ph.D.Founder
Co-Founder, Interim Chair of the Board & CEO
Kristian Reich M.D., Ph.D.Founder
Co-Founder & Chief Scientific Officer
Matthias Bodenstedt
Chief Financial Officer
Oliver Daltrop Ph.D.
Chief Technical Officer
Carla Bretes
Director of Investor Relations & External Communications
Nicolas Mosimann Ph.D.
General Counsel
Joana Cortez
Associate Vice-President of Legal & Compliance
Tino Anthamatten
Vice President of Marketing, Market Access & Pricing
Luciana Marques
Associate Vice-President of HR, People and Culture